Genesis Drug Discovery & Development
Biotechnology, 2439 Kuser Rd, Hamilton, New Jersey, 49002, United States, 1-10 Employees
Phone Number: +12*********
Who is GENESIS DRUG DISCOVERY & DEVELOPMENT
Genesis Drug Discovery and Development (GD3), a member of the Genesis Biotechnology Group is a contract research organization focused on providing services to support preclinical drug dev...
Read More
-
Headquarters: 2439 Kuser Rd, Hamilton, New Jersey, 49002, United States
-
Date Founded: 2017
-
Employees: 1-10
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8731
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from GENESIS DRUG DISCOVERY & DEVELOPMENT
Genesis Drug Discovery & Development Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Genesis Drug Discovery & Development
Answer: Genesis Drug Discovery & Development's headquarters are located at 2439 Kuser Rd, Hamilton, New Jersey, 49002, United States
Answer: Genesis Drug Discovery & Development's phone number is +12*********
Answer: Genesis Drug Discovery & Development's official website is https://gd3services.com
Answer: Genesis Drug Discovery & Development's revenue is $10 Million to $25 Million
Answer: Genesis Drug Discovery & Development's SIC: 8731
Answer: Genesis Drug Discovery & Development's NAICS: 541714
Answer: Genesis Drug Discovery & Development has 1-10 employees
Answer: Genesis Drug Discovery & Development is in Biotechnology
Answer: Genesis Drug Discovery & Development contact info: Phone number: +12********* Website: https://gd3services.com
Answer: Genesis Drug Discovery and Development (GD3), a member of the Genesis Biotechnology Group is a contract research organization focused on providing services to support preclinical drug development programs from discovery to candidate selection. Our diversified portfolio of services covers all the areas of preclinical drug discovery/development including Discovery Biology, Chemistry, DMPK/in-vivo pharmacology and Toxicology. The portfolio spans a wide range of therapeutic areas include oncology, ocular, inflammation, metabolic diseases, and microbiome.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month